End of the road for direct oral anticoagulants in thrombotic APS?
- PMID: 31685956
- DOI: 10.1038/s41584-019-0335-2
End of the road for direct oral anticoagulants in thrombotic APS?
Comment on
-
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial.Ann Intern Med. 2019 Nov 19;171(10):685-694. doi: 10.7326/M19-0291. Epub 2019 Oct 15. Ann Intern Med. 2019. PMID: 31610549 Clinical Trial.
References
Original article
-
- Ordi-Ros, J. et al. Rivaroxaban versus vitamin K antagonist in antiphospholipid syndrome: a randomized noninferiority trial. Ann. Intern. Med. https://doi.org/10.7326/M19-0291 (2019) - DOI - PubMed